初次阿片类药物处方量与全膝及全髋关节置换术后阿片类药物补充可能性之间的关联
本研究回顾性分析120,889例初次全关节置换术(76,900例全膝关节置换术和43,989例全髋关节置换术)的阿片类药物初治患者,探讨初次阿片类药物处方量与出院后30天内补充阿片类药物可能性之间的关联。结果显示,全膝关节置换术后30天补充率为59.6%,全髋关节置换术后为26.1%;初次处方量每增加75 OME,全髋关节置换术组补充的调整比值比降低2%(aOR=0.98;95% CI 0.97-0.99),全膝关节置换术组降低3%(aOR=0.97;95% CI 0.97-0.98)。作者结论认为,较大的初次阿片类药物处方量与30天补充率小幅但临床不显著的降低相关。
要点
- 全膝关节置换术后30天阿片类药物补充率为59.6%,全髋关节置换术后为26.1%。
- 初次处方量每增加75 OME,全髋关节置换术组补充的aOR=0.98(95% CI 0.97-0.99)。
- 初次处方量每增加75 OME,全膝关节置换术组补充的aOR=0.97(95% CI 0.97-0.98)。
核心结论
- 较大的初次阿片类药物处方量与全关节置换术后30天补充率小幅但临床不显著的降低相关。
- 该发现应可缓解对减少术后阿片类药物处方努力的担忧。
研究设计与样本
- 回顾性分析商业和Medicare保险理赔的大型全国数据集。
- 纳入2015年1月至2019年11月期间手术的18至75岁阿片类药物初治患者,加权队列共120,889例初次全关节置换术(76,900例全膝关节置换术和43,989例全髋关节置换术)。
- 主要结局为出院后30天内补充任何处方阿片类药物,主要预测变量为初次出院处方中填充的阿片类药物总量(以口服吗啡当量OMEs计)。
- 采用逻辑回归估计特定处方量下补充的可能性,并调整年龄、性别、合并症和手术年份等多重患者因素。
主要发现
- 全膝关节置换术后30天补充率为59.6%,全髋关节置换术后为26.1%。
- 在全髋关节置换术队列中,初次处方量每增加75 OME(10片5 mg羟考酮),补充的调整比值比降低2%(aOR=0.98;95% CI 0.97-0.99)。
- 在全膝关节置换术队列中,初次处方量每增加75 OME,补充的调整比值比降低3%(aOR=0.97;95% CI 0.97-0.98)。
关键数值与推荐
- 全髋关节置换术队列:初次处方量每增加75 OME,补充的aOR=0.98(95% CI 0.97-0.99)。
- 全膝关节置换术队列:初次处方量每增加75 OME,补充的aOR=0.97(95% CI 0.97-0.98)。
- 全膝关节置换术后30天补充率为59.6%,全髋关节置换术后为26.1%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The present study was designed to test the hypothesis that there was no association between initial opioid prescription size and the likelihood of refill after elective primary total knee (TKA) and hip arthroplasty (THA). METHODS: We retrospectively analyzed large national datasets of commercial and Medicare insurance claims to identify a weighted cohort of 120,889 primary total joint arthroplasties (76,900 TKA and 43,989 THA) comprised of opioid-naive patients aged 18 to 75 years who had surgery between January 2015 and November 2019. The primary outcome was refill of any prescription opioid medication within 30 days after discharge, and the primary predictor variable was the total amount of opioid filled in the initial discharge prescription measured in oral morphine equivalents (OMEs). Logistic regressions were used to estimate the likelihood of refill, given a particular prescription size while adjusting for multiple patient factors, including age, sex, comorbidities, and year of surgery. RESULTS: The 30-day refill rate was 59.6% following TKA and 26.1% for THA. Adjusted odds of refill decreased by 2% for every 75 OME (10 tablets of 5 mg oxycodone) increase to the initial prescription size among the THA cohort (adjusted odds ratio [OR] = 0.98; 95% CI 0.97-0.99), and decreased by 3% for the TKA cohort (aOR = 0.97; 95% CI 0.97-0.98). CONCLUSION: These nationally representative data demonstrated that larger initial opioid prescription size was associated with small but clinically insignificant decreases in 30-day refill after total joint arthroplasty. This finding should allay concerns about efforts to decrease postsurgical opioid prescribing.
引用
- Tollemar VC, Hu HM, Urquhart AG, et al. Association Between Initial Prescription Size and Likelihood of Opioid Refill After Total Knee and Hip Arthroplasty. J Arthroplasty. 2022. PMID: 36356789. doi:10.1016/j.arth.2022.10.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。